Abstract: Recruiting and retaining patients in rare disease clinical trials remains a persistent challenge, particularly when eligibility criteria are restrictive and patient populations are geographically dispersed.

Abstract: This case study highlights how Science 37 and Catalent successfully navigated the challenges of a Phase 3 rare disease neurology study for narcolepsy.

This case study highlights how Science 37 and Catalent successfully navigated the challenges of a Phase 3 rare disease neurology study for narcolepsy.

Summary: As global clinical development accelerates, managing comparator products has become a strategic imperative.

Summary: As clinical trials grow increasingly decentralised and patient-centric, traditional clinical supply chains often fall short.

Catalent’s global sourcing experts invite you to a strategic webinar focused on comparator selection and supply optimization for clinical trials.

As clinical trials grow increasingly decentralised and patient-centric, traditional clinical supply chains often fall short.

Decentralized clinical trials (DCTs) are reshaping the clinical research landscape by improving access, compliance, and operational efficiency

Discover how leveraging innovative solutions and proactive planning can transform the efficiency and reliability of your clinical supply chain.

Catalent Case Management accelerates the global delivery of ETX101, a breakthrough gene therapy from Encoded Therapeutics, designed to treat SCN1A+ Dravet syndrome.